Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis

Published:2019-09 Issue: Volume:141 Page:82-94
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Belkouz Ali^ORCID,Labeur Tim A.^ORCID,Dierks Joeri^ORCID,Dijk Frederike^ORCID,van Oijen Martijn G.H.^ORCID,Verheij Joanne,van Gulik Thomas M.,van de Vijver Marc J.^ORCID,Wilmink Hanneke,Punt Cornelis J.A.^ORCID,Klümpen Heinz-Josef^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference67 articles.

1. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document;Khan;Gut,2002

2. Surgical management of intrahepatic cholangiocarcinoma—a population-based study;Tan;Ann. Surg. Oncol.,2008

3. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies;Jarnagin;Cancer,2003

4. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent;Zhang;Br. J. Surg.,2017

5. Recurrence rate and pattern of Perihilar Cholangiocarcinoma after curative intent resection;Groot Koerkamp;J. Am. Coll. Surg.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study;Frontiers in Pharmacology;2023-10-18

2. Platelets for advanced drug delivery in cancer;Expert Opinion on Drug Delivery;2023-05-04

3. A novel prognostic system combining carbonic anhydrase II and preoperative CA19‐9 for intrahepatic cholangiocarcinoma after curative resection;Cancer;2023-01-10

4. THE NUCLEOSIDE TRANSPORTERS CNTs AND ENTs;Drug Transporters;2022-04-05

5. Biomarkers in Hepatopancreatobiliary Carcinomas;Biomarkers in Carcinoma of Unknown Primary;2022